Neuroprotection by hypoxic preconditioning involves upregulation of hypoxia-inducible factor-1 in a prenatal model of acute hypoxia

Journal of Neuroscience Research

Volumn 90, Issue 2, 2012, Pages 468-478

  Giusti, Sebastián ^a   Fiszer de Plazas, Sara ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Developing brain; Hypoxia; Preconditioning; Prolyl hydroxylases

Indexed keywords

ACTIN; ASCORBIC ACID; COBALT CHLORIDE; CYTOCHROME C; FERROUS ION; HISTONE H3; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN HYPOXIA; BRAIN INJURY; CELL SURVIVAL; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; IN VIVO STUDY; NEUROPROTECTION; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; ANOXIA; CHICK EMBRYO; CHICKENS; DISEASE MODELS, ANIMAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING; UP-REGULATION;

EID: 83155175207     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22766     Document Type: Article

References (59)

1. Althaus J, Bernaudin M, Petit E, Toutain J, Touzani O, Rami A. 2006. Expression of the gene encoding the pro-apoptotic BNIP3 protein and stimulation of hypoxia-inducible factor-1alpha (HIF-1alpha) protein following focal cerebral ischemia in rats. Neurochem Int 48: 687-695.
2. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC. 2007. Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27: 6320-6332.
3. Bernaudin M, Tang Y, Reilly M, Petit E, Sharp FR. 2002. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 277: 39728-39738.
4. Bracken CP, Fedele AO, Linke S, Balrak W, Lisy K, Whitelaw ML, Peet DJ. 2006. Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment. J Biol Chem 281: 22575-22585.
5. Bruick RK. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 97: 9082-9087.
6. Chen C, Hu Q, Yan J, Lei J, Qin L, Shi X, Luan L, Yang L, Wang K, Han J, Nanda A, Zhou C. 2007. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1alpha and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model. J Neurochem 102: 1831-1841.
7. Chen J, Simon R. 1997. Ischemic tolerance in the brain. Neurology 48: 306-311.
8. Chen W, Ostrowski RP, Obenaus A, Zhang JH. 2009. Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury. Exp Neurol 216: 7-15.
9. Chi OZ, Hunter C, Liu X, Weiss HR. 2007. Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia. Exp Neurol 204: 283-287.
10. Counts DF, Cardinale GJ, Udenfriend S. 1978. Prolyl hydroxylase half reaction: peptidyl prolyl-independent decarboxylation of alpha-ketoglutarate. Proc Natl Acad Sci U S A 75: 2145-2149.
11. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54.
12. Gage AT, Stanton PK. 1996. Hypoxia triggers neuroprotective alterations in hippocampal gene expression via a heme-containing sensor. Brain Res 719: 172-178.
13. Gidday JM. 2006. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7: 437-448.
14. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. 1994. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 168: 221-224.
15. Giusti S, Converso DP, Poderoso JJ, Fiszer de Plazas S. 2008. Hypoxia induces complex I inhibition and ultrastructural damage by increasing mitochondrial nitric oxide in developing CNS. Eur J Neurosci 27: 123-131.
16. Giusti S, Bogetti ME, Bonafina A, Fiszer de Plazas S. 2009. An improved method to obtain a soluble nuclear fraction from embryonic brain tissue. Neurochem Res 34: 2022-2029.
17. Gordan JD, Thompson CB, Simon MC. 2007. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12: 108-113.
18. Hamburger V. 1960. A manual of experimental embryology. Chicago: The University of Chicago Press. p 143-149.
19. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, Johnson RS, Lipton SA, Barlow C. 2005. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 25: 4099-4107.
20. Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, Myllyharju J. 2003. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278: 30772-30780.
21. Iadecola C, Alexander M. 2001. Cerebral ischemia and inflammation. Curr Opin Neurol 14: 89-94.
22. Kenneth NS, Rocha S. 2008. Regulation of gene expression by hypoxia. Biochem J 414: 19-29.
23. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, et al. 1990. "Ischemic tolerance" phenomenon found in the brain. Brain Res 528: 21-24.
24. Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ. 2003. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63: 1764-1768.
25. Knowles HJ, Mole DR, Ratcliffe PJ, Harris AL. 2006. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res 66: 2600-2607.
26. Lafuente JV, Bulnes S, Mitre B, Riese HH. 2002. Role of VEGF in an experimental model of cortical micronecrosis. Amino Acids 23: 241-245.
27. Lakkisto P, Csonka C, Fodor G, Bencsik P, Voipio-Pulkki LM, Ferdinandy P, Pulkki K. 2009. The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43. Scand J Clin Lab Invest 69: 209-218.
28. LaManna JC. 2007. Hypoxia in the central nervous system. Essays Biochem 43: 139-151.
29. Li Y, Zhou C, Calvert JW, Colohan AR, Zhang JH. 2005. Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia-hypotension rat model. Exp Neurol 191: 198-210.
30. Lipton P. 1999. Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
32. Lundbeck H. 2009. Safety study of carbamylated erythropoietin (CEPO) to treat patients with acute ischemic stroke. Report No. NCT00756249. See.
33. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275.
34. McDonough MA, Li V, Flashman E, Chowdhury R, Mohr C, Lienard BM, Zondlo J, Oldham NJ, Clifton IJ, Lewis J, McNeill LA, Kurzeja RJ, Hewitson KS, Yang E, Jordan S, Syed RS, Schofield CJ. 2006. Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc Natl Acad Sci U S A 103: 9814-9819.
35. Miller BA, Perez RS, Shah AR, Gonzales ER, Park TS, Gidday JM. 2001. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 12: 1663-1669.
36. Nagel S, Papadakis M, Chen R, Hoyte LC, Brooks KJ, Gallichan D, Sibson NR, Pugh C, Buchan AM. 2010. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab (in press).
37. Nietfeld JJ, Kemp A. 1981. The function of ascorbate with respect to prolyl 4-hydroxylase activity. Biochim Biophys Acta 657: 159-167.
38. Nishimura M, Sugino T, Nozaki K, Takagi Y, Hattori I, Hayashi J, Hashimoto N, Moriguchi T, Nishida E. 2003. Activation of p38 kinase in the gerbil hippocampus showing ischemic tolerance. J Cereb Blood Flow Metab 23: 1052-1059.
39. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V, Kaelin WG. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2: 423-427.
40. Pan Y, Mansfield KD, Bertozzi CC, Rudenko V, Chan DA, Giaccia AJ, Simon MC. 2007. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 27: 912-925.
41. Pozo Devoto VM, Giusti S, Chavez JC, Fiszer de Plazas S. 2008. Hypoxia-induced apoptotic cell death is prevented by oestradiol via oestrogen receptors in the developing central nervous system. J Neuroendocrinol 20: 375-380.
42. Ran R, Xu H, Lu A, Bernaudin M, Sharp FR. 2005. Hypoxia preconditioning in the brain. Dev Neurosci 27: 87-92.
43. Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17: 208-212.
44. A binding site number in developing chick optic lobe. Brain Res Dev Brain Res 124: 67-72.
45. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A. 2002. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22: 10291-10301.
46. Semenza GL. 2000. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol 59: 47-53.
47. Semenza GL. 2007. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 405: 1-9.
48. Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, Glass T, Ardizzone T, Bernaudin M. 2004. Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 1: 26-35.
49. Siddiq A, Ayoub IA, Chavez JC, Aminova L, Shah S, LaManna JC, Patton SM, Connor JR, Cherny RA, Volitakis I, Bush AI, Langsetmo I, Seeley T, Gunzler V, Ratan RR. 2005. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem 280: 41732-41743.
50. Slivka AC. 1985. Hydroxyl radical attack on dopamine. J Biol Chem 260: 15466-15472.
51. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. 2001. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 61: 6669-6673.
52. Sun FY, Guo X. 2005. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 79: 180-184.
53. Taie S, Ono J, Iwanaga Y, Tomita S, Asaga T, Chujo K, Ueki M. 2009. Hypoxia-inducible factor-1alpha has a key role in hypoxic preconditioning. J Clin Neurosci 16: 1056-1060.
54. Vacotto M, Coso O, Fiszer de Plazas S. 2008. Programmed cell death and differential JNK, p38 and ERK response in a prenatal acute hypoxic hypoxia model. Neurochem Int 52: 857-863.
55. 2 tension. Proc Natl Acad Sci U S A 92: 5510-5514.
56. Wang Y, Galvan V, Gorostiza O, Ataie M, Jin K, Greenberg DA. 2006. Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat. Brain Res 1115: 186-193.
57. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, Eckardt KU. 2003. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 17: 271-273.
58. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. 2003. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem 278: 15911-15916.
59. Zaman K, Ryu H, Hall D, O'Donovan K, Lin KI, Miller MP, Marquis JC, Baraban JM, Semenza GL, Ratan RR. 1999. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J Neurosci 19: 9821-9830.